Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genetically Engineered Extracellular Vesicles Harboring Transmembrane Scaffolds Exhibit Differences in Their Size, Expression Levels of Specific Surface Markers and Cell-Uptake

Pharmaceutics(2022)10.3390/pharmaceutics14122564Source: DataRank Database

Genetically Engineered Extracellular Vesicles Harboring Transmembrane Scaffolds Exhibit Differences in Their Size, Expression Levels of Specific Surface Markers and Cell-Uptake is a research paper published in Pharmaceutics (2022). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.65)OA: goldTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Annie Kathleen Brown ORCID,Brendan M. Johnson ORCID,David Diebold ORCID,Kyle Asano,Gerard Marriott ORCID

Live enrichment

PubMed:36559058 PMC:PMC9783873 OpenAlex:https://openalex.org/W4309723881

School of Engineering at Santa Clara University

Grant: R15GM137449

National Institutes of Health

Grant: 1R15GM137449-01

Development of a novel exosome-based enzyme replacement therapy for the treatment of human lysosomal storage disease (LSDs)

School of Engineering at Santa Clara University

FWCI

1.65

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4923/14/12/2564/pdf?version=1669176326

publisherhttps://www.mdpi.com/1999-4923/14/12/2564/pdf?version=1669176326

publisherhttps://www.mdpi.com/1999-4923/14/12/2564/pdf

journalhttps://doi.org/10.3390/pharmaceutics14122564

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36559058

Fields of Study

Extracellular vesicles in diseaseinterferon and immune responsesNanoplatforms for cancer theranostics0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Extracellular vesiclesCell biologyTransmembrane proteinVesicleCellExtracellularGenetically engineeredChemistryBiophysicsBiologyBiochemistryMembraneGeneReceptorCD81ExosomeNanotechnologyTargeted Drug DeliveryCd9Cd63Extracellular Vesicles (Evs)Vesicular Stomatitis Virus Envelope Glycoprotein (Vsvg)610BioengineeringPharmacology and Pharmaceutical SciencesArticle620RS1-441Pharmacy and materia medicavesicular stomatitis virus envelope glycoproteinBiotechnologyCancer

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being